- Home
- MGPI vs QURE Comparison
MGPI vs QURE Comparison
Compare MGPI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- QURE
- Stock Information
- Founded
- MGPI 1941
- QURE 1998
- Country
- MGPI United States
- QURE Netherlands
- Employees
- MGPI N/A
- QURE N/A
- Industry
- MGPI Beverages (Production/Distribution)
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- QURE Health Care
- Exchange
- MGPI Nasdaq
- QURE Nasdaq
- Market Cap
- MGPI 626.9M
- QURE 725.4M
- IPO Year
- MGPI 1988
- QURE 2007
- Fundamental
- Price
- MGPI $31.23
- QURE $14.87
- Analyst Decision
- MGPI Strong Buy
- QURE Strong Buy
- Analyst Count
- MGPI 5
- QURE 10
- Target Price
- MGPI $45.40
- QURE $37.20
- AVG Volume (30 Days)
- MGPI 275.2K
- QURE 1.1M
- Earning Date
- MGPI 07-31-2025
- QURE 07-31-2025
- Dividend Yield
- MGPI 1.54%
- QURE N/A
- EPS Growth
- MGPI N/A
- QURE N/A
- EPS
- MGPI 0.50
- QURE N/A
- Revenue
- MGPI $654,715,000.00
- QURE $20,201,000.00
- Revenue This Year
- MGPI N/A
- QURE N/A
- Revenue Next Year
- MGPI N/A
- QURE $278.91
- P/E Ratio
- MGPI $62.18
- QURE N/A
- Revenue Growth
- MGPI N/A
- QURE 6.30
- 52 Week Low
- MGPI $25.12
- QURE $4.45
- 52 Week High
- MGPI $92.52
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- MGPI 53.82
- QURE 53.70
- Support Level
- MGPI $31.24
- QURE $14.03
- Resistance Level
- MGPI $33.38
- QURE $14.75
- Average True Range (ATR)
- MGPI 1.23
- QURE 0.72
- MACD
- MGPI 0.22
- QURE -0.02
- Stochastic Oscillator
- MGPI 52.12
- QURE 73.91
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.